Your Messages Inbox
Your Article Summary
See Latest ArticlesAVI BioPharma, Inc. Appoints Paul Medeiros as Chief Business Officer
AVI BioPharma, 05/19/09
AVI BioPharma, Inc. , a developer of RNA-based drugs, announced the appointment of Paul Medeiros as Senior Vice President of Business Development and Chief Business Officer. Medeiros has more than 17 years experience in pharmaceutical and biotechnology business development and most recently served as Vice President, Global Licensing and Strategic Alliances for Schering-Plough, where he led worldwide specialty product licensing and strategic partnering initiatives. Medeiros has significant licensing experience and a track record of success in technology acquisitions, in- and out-licensed products and strategic alliances across several therapeutic areas.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Bristol Myers-Squibb Company, 12/15/09
AHIMA Selects its Leader
HealthDataManagement, 12/14/09
Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09
Article Search
Sponsor